<p>Initial (Day 1) and final (Day 5) body weight in different groups: SHAM+CTRL (sham procedure followed by sleep control condition, n = 10), SHAM+PSD (sham procedure followed by 48 h of paradoxical sleep deprivation, n = 10), PSO+CTRL (psoriasis induction followed by sleep control condition, n = 11), PSO+PSD (psoriasis induction followed by 48 h of paradoxical sleep deprivation, n = 8) and PSO+SR48 (psoriasis induction followed by 48 h of sleep rebound, n = 10). *p<0.05 compared to respective initial body weight. Values expressed as mean ± SEM.</p
OBJECTIVE: Our aim was to assess the role of the body mass index (BMI) in the clinical response to s...
Meta-analysis of mean difference in BMI (kg/m2) between psoriasis cases and controls. MD of 1.26 kg/...
<p>(A) Evolution of daily body weight within each generation from PVM inoculation to 7 days later (%...
<p>Skin kallikrein-5 (K5) activity (nmol.mg<sup>−1</sup>.min<sup>−1</sup>) in different groups: SHAM...
<p>Body weight change (g) of the C (n = 10), RT (n = 10), PSD96 (n = 10), RT/PSD96 (n = 10) groups d...
<p>Plasma concentration of cytokines IFNγ (pg/mL), IL-2 (pg/mL), TNFα (pg/mL) and IL-17 (pg/mL) in d...
<p>Experimental timeline for each condition: SHAM+CTRL (sham procedure followed by sleep control con...
<p>Plasma concentration of cytokines <b>A</b>) IL-1β (pg/mL), <b>B</b>) IL-6 (pg/mL), <b>C</b>) IL-1...
<p>The body weights of each group are shown on line graphs for each week. Values are expressed as me...
<p>Values are means (SD) for normally distributed variables and median (interquartile range, IQR) fo...
<p>Mean and standard deviation values of gain and phase in all room movement cycles in pre-change, c...
Objective: Our aim was to assess the role of the body mass index (BMI) in the clinical response to s...
Objective: Our aim was to assess the role of the body mass index (BMI) in the clinical response to s...
<p>B. Body weight change (% of the beginning body weight) during the treatment. One way ANOVA Dunnet...
Data are given as mean ± standard error. (A) Control ♀: n = 7, single anesthesia ♀: n = 13, repeated...
OBJECTIVE: Our aim was to assess the role of the body mass index (BMI) in the clinical response to s...
Meta-analysis of mean difference in BMI (kg/m2) between psoriasis cases and controls. MD of 1.26 kg/...
<p>(A) Evolution of daily body weight within each generation from PVM inoculation to 7 days later (%...
<p>Skin kallikrein-5 (K5) activity (nmol.mg<sup>−1</sup>.min<sup>−1</sup>) in different groups: SHAM...
<p>Body weight change (g) of the C (n = 10), RT (n = 10), PSD96 (n = 10), RT/PSD96 (n = 10) groups d...
<p>Plasma concentration of cytokines IFNγ (pg/mL), IL-2 (pg/mL), TNFα (pg/mL) and IL-17 (pg/mL) in d...
<p>Experimental timeline for each condition: SHAM+CTRL (sham procedure followed by sleep control con...
<p>Plasma concentration of cytokines <b>A</b>) IL-1β (pg/mL), <b>B</b>) IL-6 (pg/mL), <b>C</b>) IL-1...
<p>The body weights of each group are shown on line graphs for each week. Values are expressed as me...
<p>Values are means (SD) for normally distributed variables and median (interquartile range, IQR) fo...
<p>Mean and standard deviation values of gain and phase in all room movement cycles in pre-change, c...
Objective: Our aim was to assess the role of the body mass index (BMI) in the clinical response to s...
Objective: Our aim was to assess the role of the body mass index (BMI) in the clinical response to s...
<p>B. Body weight change (% of the beginning body weight) during the treatment. One way ANOVA Dunnet...
Data are given as mean ± standard error. (A) Control ♀: n = 7, single anesthesia ♀: n = 13, repeated...
OBJECTIVE: Our aim was to assess the role of the body mass index (BMI) in the clinical response to s...
Meta-analysis of mean difference in BMI (kg/m2) between psoriasis cases and controls. MD of 1.26 kg/...
<p>(A) Evolution of daily body weight within each generation from PVM inoculation to 7 days later (%...